1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH), Department of Health and Human Services. BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH), Depa…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Frequently Asked Questions - BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa | NHLBI, NIH Frequently Asked Questions - BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa Frequently Asked Questions - BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa Q1.
What countries are part of Sub-Saharan Africa (SSA)? A1. Please refer to Sub-Saharan African Region Information provided by the Fogarty International Center of NIH .
Q2. Is a component of a US institution in a low-income or lower-middle income country in Sub-Saharan Africa eligible to apply? A2.
Yes, if the component of a US institution in a low-income or lower-middle income country in Sub-Saharan Africa is able to submit grant applications to and receive awards from NIH directly without going through the US institution. This also applies to a component of any other country’s institution in a low-income or lower-middle income country in Sub-Saharan Africa. Q3.
Can an investigator from a country outside of Sub-Saharan Africa or from a country that is not low-income or lower-middle income serve as a co-PI? A3. Yes, as long as the primary PI is from an institution in a low-income or lower-middle income country of Sub-Saharan Africa, that is, the institution in a low-income or lower-middle income country of Sub-Saharan Africa will be the grantee institution.
Investigators from a country outside of Sub-Saharan Africa or from a country that is not low-income or lower-middle income can also serve as co-investigators or consultants. Q4. The FOA indicated only one award per country.
What will happen if two different PIs from the same eligible country and their respective teams of investigators submitted two different applications? A4. The idea of having only one award per country is to have as many countries represented in the final consortium as possible and also to discourage one primary PI from submitting more than one application.
If two different (primary) PIs from the same eligible country submitted two different applications, both applications will be evaluated by the peer review panel with consideration of an award based on scientific merit.
According to the current listing, eligibility includes: Native American tribal organizations (other than Federally recognized tribal governments), Public and State controlled institutions of higher education, Small businesses, City or township governments, For profit organiz…. Confirm the full requirements in the official notice before applying.
The current listing shows $415,000 (Award Ceiling). Verify award ceilings, matching requirements, and allowable costs in the official notice.
BLOODSAFE: Research to enhance availability of safe blood for patients with severe anemia and hemorrhagic conditions in low or lower-middle income countries (LLMICs) in Sub-Saharan Africa (UG3/UH3 Clinical Trial Optional) is funded by National Institutes of Health (NIH), Department of Health and Human Services. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Discovery and Applied Research for Technological Innovations to Improve Human Health is sponsored by National Institutes of Health (NIH), Department of Health and Human Services. This program supports hypothesis-, design-, technology-, or device-driven research related to the discovery, design, development, validation, and application of technologies for biomedical imaging and bioengineering.
Serious STEM Games for Pre-College and Informal Science Education Audiences (STTR) (R41/R42) is sponsored by National Institutes of Health (NIH), Department of Health and Human Services. This Funding Opportunity Announcement (FOA) provides opportunities for eligible small business concerns to submit STTR grant applications to develop serious Science, Technology, Engineering and Mathematics (STEM) games with a focus on biology that addresses health and medicine q…
The Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read articleThe joint NSF-NIH Smart Health and Biomedical Research solicitation supports high-risk, high-reward AI/data science work in health — $300K per year for four years, with 20+ NIH institutes participating. Here is how the program actually selects winners.
Read article